H.C. Wainwright Keeps Their Buy Rating on IVERIC bio (ISEE)

H.C. Wainwright Keeps Their Buy Rating on IVERIC bio (ISEE)

H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating on IVERIC bio (ISEE – Research Report) today and set a price target of $3...

Related Keywords

New York , United States , Samir Chandrakant Patel , Matthew Caufield , Dugel Pravin , Davidr Guyer , Ocuphire Pharma , , Research Report , Moderate Buy ,

© 2025 Vimarsana